Multidisciplinary consensus on the management of dyslipidemia in patients with atherosclerotic vascular disease in Galicia

Abstract

Cardiovascular Disease (CVD) is the leading cause of death in Galicia. The main component of CVD is Atherosclerotic Vascular Disease (AVD), whose main clinical manifestations are ischemic heart disease, ischemic cerebrovascular disease, or peripheral artery disease. On the other hand, these diseases are associated with a great economic and social impact. The causal role of LDL-C as an etiologic agent of Atherosclerotic Vascular Disease has been demonstrated in multiple studies, as well as the beneficial effect of keeping LDL-C levels low for as long as possible to decrease cardiovascular morbidity and mortality. Despite the wide range of lipid-lowering therapies, real-life studies have shown that most patients do not achieve the LDL-c goals set by clinical practice guidelines according to their CV risk. Therefore, to improve the lipid control of patients with Atherosclerotic Vascular Disease in Galicia, a treatment algorithm agreed upon by the different medical specialties is proposed, including recommendations for the patients’ follow-up to ensure continuity of care.